CEL SCI Corp (CVM) stock
CVMNYSEBiological Products, (No Diagnostic Substances)Fiscal year ends September 30
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Aug 14, 2026Score 1/30
$1.38−0.47 (-25.41%)
Close on Nov 18, 2026Market cap $24.27MP/E –Yield –
Cel Sci revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
For fiscal 2014 it was $264.03K, up 65.5% from the year before.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2014 | Sep 30, 2014 | $264.03K | +65.5% |
| FY2013 | Sep 30, 2013 | $159.58K | -37.3% |
| FY2012 | Sep 30, 2012 | $254.61K | -73.4% |
| FY2011 | Sep 30, 2011 | $956.15K | – |
Quarterly revenue
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2017CQ2 2017 | Jun 30, 2017 | $17.39K | – |
See a number that looks wrong?